IPCA LABORATORIES @ CMP 767
Ipca Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 9,690.20 crore. It is a 2.00 face value stock with EPS of 43.67 and P/E of 17.6 which seems very attractive for a pharma company. Few days back when it was trading near 900, it got stuck by USFDA due to some obligations in its ratlam unit and price of the stock fell by about 25%. But from fundamental point of view, there is no harm in the stock and the company capable in resolving the issue. So this mid-cap stock currently trading at attractive LTP/ BV value of about 4.5, least in its competitors.
– Company has good consistent profit growth of 22.58% over 5 years